Literature DB >> 16489745

Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium.

Rachel K Hopper1, Stefanie Carroll, Angel M Aponte, D Thor Johnson, Stephanie French, Rong-Fong Shen, Frank A Witzmann, Robert A Harris, Robert S Balaban.   

Abstract

Post-translational modification of mitochondrial proteins by phosphorylation or dephosphorylation plays an essential role in numerous cell signaling pathways involved in regulating energy metabolism and in mitochondrion-induced apoptosis. Here we present a phosphoproteomic screen of the mitochondrial matrix proteins and begin to establish the protein phosphorylations acutely associated with calcium ions (Ca(2+)) signaling in porcine heart mitochondria. Forty-five phosphorylated proteins were detected by gel electrophoresis-mass spectrometry of Pro-Q Diamond staining, while many more Pro-Q Diamond-stained proteins evaded mass spectrometry detection. Time-dependent (32)P incorporation in intact mitochondria confirmed the extensive matrix protein phosphoryation and revealed the dynamic nature of this process. Classes of proteins that were detected included all of the mitochondrial respiratory chain complexes, as well as enzymes involved in intermediary metabolism, such as pyruvate dehydrogenase (PDH), citrate synthase, and acyl-CoA dehydrogenases. These data demonstrate that the phosphoproteome of the mitochondrial matrix is extensive and dynamic. Ca(2+) has previously been shown to activate various dehydrogenases, promote the generation of reactive oxygen species (ROS), and initiate apoptosis via cytochrome c release. To evaluate the Ca(2+) signaling network, the effects of a Ca(2+) challenge sufficient to release cytochrome c were evaluated on the mitochondrial phosphoproteome. Novel Ca(2+)-induced dephosphorylation was observed in manganese superoxide dismutase (MnSOD) as well as the previously characterized PDH. A Ca(2+) dose-dependent dephosphorylation of MnSOD was associated with an approximately 2-fold maximum increase in activity; neither the dephosphorylation nor activity changes were induced by ROS production in the absence of Ca(2+). These data demonstrate the use of a phosphoproteome screen in determining mitochondrial signaling pathways and reveal new pathways for Ca(2+) modification of mitochondrial function at the level of MnSOD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489745      PMCID: PMC1415274          DOI: 10.1021/bi052475e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest.

Authors:  S Wang; M Guo; H Ouyang; X Li; C Cordon-Cardo; A Kurimasa; D J Chen; Z Fuks; C C Ling; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 2.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  Evidence of undiscovered cell regulatory mechanisms: phosphoproteins and protein kinases in mitochondria.

Authors:  M Thomson
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

4.  Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis.

Authors:  M Y Cao; F Shinjo; S Heinrichs; J W Soh; J Jongstra-Bilen; J Jongstra
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

Review 5.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.

Authors:  E J Lesnefsky; S Moghaddas; B Tandler; J Kerner; C L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

6.  Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase.

Authors:  F Kernec; M Unlü; W Labeikovsky; J S Minden; A P Koretsky
Journal:  Physiol Genomics       Date:  2001-07-17       Impact factor: 3.107

7.  p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD.

Authors:  H Harada; J S Andersen; M Mann; N Terada; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

8.  Ca(2+) activation of heart mitochondrial oxidative phosphorylation: role of the F(0)/F(1)-ATPase.

Authors:  P R Territo; V K Mootha; S A French; R S Balaban
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

9.  A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells.

Authors:  C Guo; S Yu; A T Davis; H Wang; J E Green; K Ahmed
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

10.  Characterization of dynamic and steady-state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry.

Authors:  Birte Schulenberg; Terrie N Goodman; Robert Aggeler; Roderick A Capaldi; Wayne F Patton
Journal:  Electrophoresis       Date:  2004-08       Impact factor: 3.535

View more
  115 in total

1.  Regulation of oxidative phosphorylation complex activity: effects of tissue-specific metabolic stress within an allometric series and acute changes in workload.

Authors:  Darci Phillips; Raul Covian; Angel M Aponte; Brian Glancy; Joni F Taylor; David Chess; Robert S Balaban
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

Review 2.  Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.

Authors:  Michael N Sack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

Review 3.  What can we learn about cardioprotection from the cardiac mitochondrial proteome?

Authors:  Marjan Gucek; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2010-08-30       Impact factor: 10.787

4.  Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria.

Authors:  Ning Deng; Jun Zhang; Chenggong Zong; Yueju Wang; Haojie Lu; Pengyuan Yang; Wenhai Wang; Glen W Young; Yibin Wang; Paavo Korge; Christopher Lotz; Philip Doran; David A Liem; Rolf Apweiler; James N Weiss; Huilong Duan; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2010-05-22       Impact factor: 5.911

5.  Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria.

Authors:  Etienne Hébert Chatelain; Jean-William Dupuy; Thierry Letellier; Jeanne Dachary-Prigent
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

Review 6.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  The mitochondrial permeability transition pore regulates endothelial bioenergetics and angiogenesis.

Authors:  Raluca Marcu; Surya Kotha; Zhongwei Zhi; Wan Qin; Christopher K Neeley; Ruikang K Wang; Ying Zheng; Brian J Hawkins
Journal:  Circ Res       Date:  2015-02-26       Impact factor: 17.367

Review 8.  Uncoupling protein 1: a short-circuit in the chemiosmotic process.

Authors:  Richard K Porter
Journal:  J Bioenerg Biomembr       Date:  2008-10-29       Impact factor: 2.945

9.  Phosphorylation of Cytochrome c Threonine 28 Regulates Electron Transport Chain Activity in Kidney: IMPLICATIONS FOR AMP KINASE.

Authors:  Gargi Mahapatra; Ashwathy Varughese; Qinqin Ji; Icksoo Lee; Jenney Liu; Asmita Vaishnav; Christopher Sinkler; Alexandr A Kapralov; Carlos T Moraes; Thomas H Sanderson; Timothy L Stemmler; Lawrence I Grossman; Valerian E Kagan; Joseph S Brunzelle; Arthur R Salomon; Brian F P Edwards; Maik Hüttemann
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

10.  Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle.

Authors:  K Højlund; Z Yi; N Lefort; P Langlais; B Bowen; K Levin; H Beck-Nielsen; L J Mandarino
Journal:  Diabetologia       Date:  2009-12-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.